Kenya National Cancer Control Programme (NCCP) FHIR Implementation Guide, published by Digital Health Agency (DHA), Kenya. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/IntelliSOFT-Consulting/nccpFHIRIG/ and changes regularly. See the Directory of published versions
Profile: NCCP Chemotherapy Medication Request
Cycle Day Start Extension: 1
Cycle Day End Extension: 1
Clinical Category Extension: CHEMOTHERAPY
identifier: NCCPMedRequestId/MR-2026-00301
status: Active
intent: Order
category: Inpatient
medication: Doxorubicin
subject: Mary Wanjiku Female, DoB: 1975-06-15
authoredOn: 2026-01-10
requester: Practitioner James Otieno
reasonReference: Condition C50 — Malignant neoplasm of breast
basedOn: CarePlan: status = active; intent = plan
dosageInstruction
route: Intravenous
DoseAndRates
Dose[x] 60 mg/m2 (Details: Kenya Oncology Unit of Measure Code System codeMG-PER-M2 = 'mg/m²')